Sickle Cell Disease
Sickle Cell Disease is a topic covered in the Washington Manual of Medical Therapeutics.
To view the entire topic, please log in or purchase a subscription.
The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
General Principles
- SCD is a group of hereditary Hgb disorders in which Hgb undergoes a sickle shape transformation under conditions of deoxygenation.
- The most common are homozygous sickle cell anemia (Hgb SS) or other double-heterozygous conditions (Hgb SC, Hgb S–β0, or Hgb S–β+ thalassemia).
- Newborn screening programs for hemoglobinopathies are available throughout the US and identify most patients in infancy.
- In the US, the incidence of SCD is approximately 1 in 625 births.
- Sickle cell trait is present in 7%–8% of African Americans. It is generally considered to be a benign carrier state, but high-altitude hypoxia is associated with splenic infarction, whereas intense physical exertion has been associated with sudden death and rhabdomyolysis.
- Sickle cell trait has been associated with an increased risk of pulmonary embolism, proteinuria, and CKD. Minimizing other risk factors for kidney disease is likely to benefit patients at risk.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
General Principles
- SCD is a group of hereditary Hgb disorders in which Hgb undergoes a sickle shape transformation under conditions of deoxygenation.
- The most common are homozygous sickle cell anemia (Hgb SS) or other double-heterozygous conditions (Hgb SC, Hgb S–β0, or Hgb S–β+ thalassemia).
- Newborn screening programs for hemoglobinopathies are available throughout the US and identify most patients in infancy.
- In the US, the incidence of SCD is approximately 1 in 625 births.
- Sickle cell trait is present in 7%–8% of African Americans. It is generally considered to be a benign carrier state, but high-altitude hypoxia is associated with splenic infarction, whereas intense physical exertion has been associated with sudden death and rhabdomyolysis.
- Sickle cell trait has been associated with an increased risk of pulmonary embolism, proteinuria, and CKD. Minimizing other risk factors for kidney disease is likely to benefit patients at risk.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Sickle Cell Disease." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602065/all/Sickle_Cell_Disease.
Sickle Cell Disease. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602065/all/Sickle_Cell_Disease. Accessed March 27, 2023.
Sickle Cell Disease. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602065/all/Sickle_Cell_Disease
Sickle Cell Disease [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 March 27]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602065/all/Sickle_Cell_Disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sickle Cell Disease
ID - 602065
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602065/all/Sickle_Cell_Disease
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -